About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Sanofi-Aventis' Malaria Drug ASAQ as Effective as Novartis' Coartem

by Medindia Content Team on November 9, 2007 at 5:56 PM
Font : A-A+

Sanofi-Aventis' Malaria Drug ASAQ as Effective as Novartis' Coartem

Sanofi-Aventis' fixed-dose combination malaria drug ASAQ is as effective as Novartis' Coartem in treating people with uncomplicated Plasmodium falciparum malaria, Sanofi reported Wednesday at the annual meeting of the American Society of Tropical Medicine and Hygiene in Philadelphia.

ASAQ is composed of artemisinin and amodiaquine, and a full course will be available for less than $1 for adults and 50 cents for children. Sanofi said it also intends to produce a branded version of the drug, called Coarsucam, for the private market.

Advertisement

The private market version will be priced three to four times higher than the public price. The drug has been registered in 11 countries in Africa, and 10 million treatment courses are expected to be sold this year.

The trial, which was conducted from March 2006 to January 2007, involved 941 people, 433 of whom were children younger than age five, in Cameroon, Madagascar, Mali and Senegal, where both combination therapies are recommended by the World Health Organization.
Advertisement

The participants were divided into three treatment groups, and "tolerance proved satisfactory" in all three groups, the study said. The company said the drug's regimen of once-a-day for three days promotes treatment compliance. ASAQ was developed in conjunction with the Drugs for Neglected Diseases Initiative.

Source: Kaiser Family Foundation
LIN/C
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Sensory Processing Disorder (SPD)
First Dose of COVID-19 Vaccines May Improve Mental Health
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Malaria-water Malaria Mosquito Diseases Signature Drug Toxicity Fever Malaria - Protection Strategies 

Recommended Reading
Malaria
Malaria is caused by a parasite that enters blood through the bite of an infected mosquito. It is .....
Biotech Company Sanaria To Open New Malaria Vaccine Plant
Biotechnology company Sanaria in Rockville, Md., plans to open a new malaria vaccine plant....
Introducing New 'Hi Protection', 'Hi Safe' Malaria Vaccine
Tests affirm that the new malarial vaccine 'Mosquirix' rendered a high level of protection and ......
Glaxo’s Malaria Vaccine Trials Prove Promising
One more milestone seems to have been crossed in the quest for a malaria vaccine. Trials in rural .....
Drug Toxicity
Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a d...
Fever
Fever or Pyrexia is an elevation in normal body temperature. Causes of fever include infections, inj...
Malaria - Protection Strategies
Malaria is a dangerous disease with lethal consequences that requires protective measures for preven...
Mosquito Diseases
Mosquito-borne diseases, like malaria, filaria, dengue, etc are common in places conducive of mosqu...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use